With interest we read the systematic review by Liakopoulos et al. 1 In their meta-analysis of mainly observational studies, the authors conclude that the early clinical outcome is substantially improved in statin pre-treated patients. The authors correctly address an unequal distribution of potentially confounding factors among patient groups as a limitation for the correct interpretation of their results. More explicitly, factors such as pre-operative treatment with b-blocker may indeed contribute in a substantial way to the outcome of their meta-analysis. The authors report treatment with b-blocker to be significantly 1.3-fold more frequent in the group of statin-treated patients with P , 0.01. Just to elucidate the strength of this potential confound: the precise significance level is P ¼ 3 Â 10 2127 based on a two-sided Fisher's exact t-test.
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Observational studies underlying this meta-analysis already report and discuss group differences in the underlying risk factors and their management 2 -4 as well as group differences in the emergency status of the cardiac surgery 2 as significant contributors to an effect on post-operative outcomes. Clinically relevant conclusions may, therefore, rely on the convincing negative outcomes of the study of Ali and Buth until randomized controlled trials may show a beneficial effect of pre-operative statin therapy on early post-operative adverse outcomes in cardiac surgery patients.
Still without impact on adverse post-operative outcomes: pre-operative statin therapy in patients undergoing cardiac surgery: reply
We appreciate the authors' comments and thank them for emphasizing several limitations that must be considered for accurate interpretation of the reported statin treatment effects in our systematic review. As correctly stated in their comment, our analysis identified an unequal distribution of potentially confounding factors among patient groups, including a significantly higher prevalence of a b-blocker and aspirin therapy in statin pre-treated patients (P , 0.001). In large observational trials, the use of both b-blocker and aspirin has been associated with decreased mortality and morbidity following cardiac surgery.
1,2 The importance of this treatment bias with unknown impact on the presented results is highlighted in detail in the limitation section and must be taken seriously into account when interpreting the results of our meta-analysis. Furthermore, assessment of odds ratios (ORs) was performed after a detailed review and extraction of all available raw data from the included studies. The unadjusted 'crude' OR was determined when complete data sets from risk-adjusted treatment groups were not reported in the respective studies. Given the fact that adjustment for covariates and 
